Opioid Treatment Program (OTP)-Pharmacy Collaboration for Methadone Maintenance Treatment

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 6, 2020

Primary Completion Date

January 5, 2021

Study Completion Date

January 18, 2021

Conditions
Opioid-use Disorder
Interventions
DRUG

Pharmacy-based methadone administration and dispensing

Eligible participants receiving between 6- and 13-days of methadone take-home doses will have methadone administration and dispensing transferred from the opioid treatment program to the partnered community pharmacy. Each participant will be assessed monthly for 3 months (at 1, 2, and 3 months following intake/baseline) to explore the feasibility of transferring their methadone administration and dispensing to the select community pharmacy.

Trial Locations (3)

27597

Morse Clinic of Zebulon, Zebulon

27615

Health Park Pharmacy, Raleigh

Morse Clinic of North Raleigh, Raleigh

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Duke Health

OTHER

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Friends Research Institute, Inc.

OTHER

NCT04308694 - Opioid Treatment Program (OTP)-Pharmacy Collaboration for Methadone Maintenance Treatment | Biotech Hunter | Biotech Hunter